Immune checkpoint inhibitor-induced myocarditis is dependent on CD8 T cell-derived TNF and TNFR2 signaling.

Saved in:
Bibliographic Details
Title: Immune checkpoint inhibitor-induced myocarditis is dependent on CD8 T cell-derived TNF and TNFR2 signaling.
Authors: Warrick KA; Immunology Graduate Program, Cincinnati Children's Hospital Medical Center and University of Cincinnati , Cincinnati, OH, USA.; Medical Scientist Training Program, University of Cincinnati College of Medicine , Cincinnati, OH, USA.; Division of Molecular Cardiovascular Biology, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Division of Immunobiology and Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Johansen AKZ; Division of Molecular Cardiovascular Biology, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Jiao M; Division of Immunobiology and Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Linnemann ME; Medical Sciences Undergraduate Program, University of Cincinnati College of Medicine , Cincinnati, OH, USA., Saha I; Division of Immunobiology and Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Lin SJ; Division of Molecular Cardiovascular Biology, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Vallez CN; Immunology Graduate Program, Cincinnati Children's Hospital Medical Center and University of Cincinnati , Cincinnati, OH, USA.; Medical Scientist Training Program, University of Cincinnati College of Medicine , Cincinnati, OH, USA.; Division of Immunobiology and Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Hagan T; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Molkentin JD; Division of Molecular Cardiovascular Biology, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Pasare C; Division of Immunobiology and Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Source: The Journal of experimental medicine [J Exp Med] 2026 Apr 06; Vol. 223 (4). Date of Electronic Publication: 2026 Feb 20.
Publication Type: Journal Article
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20251717